Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3199 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2934 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-18 | 88207 |
| TEVA-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-25 | 88210 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Resolved | 2020-10-30 | 2021-02-12 | 127622 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Resolved | 2020-12-17 | 2021-02-12 | 130319 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3130 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5213 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86606 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86884 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2019-11-28 | 2025-04-28 | 99938 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2020-07-30 | 2025-04-28 | 121497 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2021-02-18 | 2025-04-28 | 134352 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116669 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2020-07-30 | 2020-09-17 | 121512 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2020-10-01 | 2020-11-26 | 125506 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2021-11-04 | 2021-11-11 | 148841 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2023-07-11 | 2023-10-04 | 198312 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2024-06-07 | 2024-09-19 | 229951 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2025-07-18 | 2025-11-20 | 263134 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-10-05 | 2024-08-27 | 206389 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |